Molecular Templates (MTEM) Stock Statistics & Valuation Metrics

Molecular Templates has a market cap or net worth of $658.00. The enterprise value is ―.

Molecular Templates has 6,583,880 shares outstanding. The number of shares has decreased by -2.65% in one year.

Molecular Templates’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Molecular Templates is -0.14. Molecular Templates’s PEG ratio is <0.01.

In the last 12 months, Molecular Templates had revenue of 57.31M and earned -8.12M in profits. Earnings per share was -1.80.

In the last 12 months, operating cash flow was -23.92M and capital expenditures 0.00, giving a free cash flow of -23.92M billion.

Molecular Templates pays an annual dividend of ―, resulting in a dividend yield of ―

Molecular Templates upcoming earnings date is May 19, 2025, TBA Not Confirmed.

Molecular Templates as a current ratio of 0.97, with Debt / Equity ratio of 155.07%

In the past 12 months, Molecular Templates has paid -11.00K in taxes.

Molecular Templates EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Molecular Templates has $9.66M in cash and marketable securities with $13.93M in debt, giving a net cash position of $1.37M billion.

Gross margin is 63.35%, with operating margin of -18.26%, and net profit margin of -14.18%.

The average price target for Molecular Templates is ―, which is 11.43% higher than the current price. The consensus rating is ―